• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,968.06 -520.90
( -0.68%)
Global Indices
Nasdaq
50,600.70 294.03
(0.58%)
Dow Jones
7,494.47 27.75
(0.37%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,466.26 22.79
(0.22%)
Forex
USD-INR
95.61 -0.67
(-0.70%)
EUR-INR
110.97 -0.85
(-0.76%)
GBP-INR
128.43 -0.86
(-0.66%)
JPY-INR
0.60 0.00
(-0.79%)

EQUITY - MARKET SCREENER

Amanta Healthcare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
544502
INE084K01015
56.7120864
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AMANTA
31.37
515.27
EPS(TTM)
Face Value()
Div & Yield %
4.23
10
0
 

Cyient consolidated net profit declines 67.84% in the March 2026 quarter
Apr 24,2026
Net profit of Cyient declined 67.84% to Rs 54.80 crore in the quarter ended March 2026 as against Rs 170.40 crore during the previous quarter ended March 2025. Sales rose 0.93% to Rs 1926.90 crore in the quarter ended March 2026 as against Rs 1909.20 crore during the previous quarter ended March 2025.

For the full year,net profit declined 30.50% to Rs 427.90 crore in the year ended March 2026 as against Rs 615.70 crore during the previous year ended March 2025. Sales declined 1.25% to Rs 7268.20 crore in the year ended March 2026 as against Rs 7360.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1926.901909.20 1 7268.207360.40 -1
OPM %11.5215.63 -12.3715.47 -
PBDT234.10320.40 -27 1015.501142.20 -11
PBT166.20252.50 -34 737.30875.00 -16
NP54.80170.40 -68 427.90615.70 -31